Jesse Boehm, PhD

Scientific Director, Cancer Dependency Map
The Broad Institute of MIT and Harvard

Jesse is the Scientific Director of the Broad Institute’s Cancer Dependency Map and an Institute Scientist at the Broad. He leads a research laboratory focused on developing technologies to perturb living patient tissues ex vivo including creating patient models from rare tumor types and genotypes (Cancer Cell Line Factory; CCLF) to support the Broad’s Dependency Map Initiative and the use of single cell imaging biosensors for rapid ex vivo dependency assessment. The Boehm Lab has an ultimate goal of making “precision functional genomics” a reality for cancer patients. Jesse received his B.S. in biology from MIT and his Ph.D. from Harvard University, Division of Medical Sciences.